Similar articles

• Auranofin in the treatment of rheumatoid arthritis. A two-year study.

  Baldassare AR, Weiss TD, Arthur RE, Osborn TG, Moore TL, Zuckner J. Baldassare AR, et al. Mo Med. 1985 Nov;82(11):711-5. Mo Med. 1985. PMID: 3934512 Clinical Trial. No abstract available.
• Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study.

  van Riel PL, van de Putte LB, Gribnau FW, Macrae KD. van Riel PL, et al. Clin Rheumatol. 1984 Mar;3 Suppl 1:51-6. doi: 10.1007/BF03342622. Clin Rheumatol. 1984. PMID: 6432414 Clinical Trial.
• [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].

  Rainer F, Ulreich A. Rainer F, et al. Wien Klin Wochenschr Suppl. 1984;156:49-51. Wien Klin Wochenschr Suppl. 1984. PMID: 6442058 German. No abstract available.
• Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.

  Chaffman M, Brogden RN, Heel RC, Speight TM, Avery GS. Chaffman M, et al. Drugs. 1984 May;27(5):378-424. doi: 10.2165/00003495-198427050-00002. Drugs. 1984. PMID: 6426923 Review.
• Comparison of oral and parenteral gold therapy and placebo in the treatment of rheumatoid arthritis.

  Williams HJ, Ward JR. Williams HJ, et al. Scand J Rheumatol Suppl. 1983;51:92-9. doi: 10.3109/03009748309095360. Scand J Rheumatol Suppl. 1983. PMID: 6426054 Review.